Amplifon Past Earnings Performance

Past criteria checks 2/6

Amplifon has been growing earnings at an average annual rate of 12.1%, while the Healthcare industry saw earnings growing at 16.8% annually. Revenues have been growing at an average rate of 9.1% per year. Amplifon's return on equity is 13.9%, and it has net margins of 6.6%.

Key information

12.1%

Earnings growth rate

12.0%

EPS growth rate

Healthcare Industry Growth	13.4%
Revenue growth rate	9.1%
Return on equity	13.9%
Net Margin	6.6%
Next Earnings Update	06 Mar 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Amplifon makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BMV:AMP1 N Revenue, expenses and earnings (EUR Millions)
Date	Revenue	Earnings	G+A Expenses
30 Sep 24	2,360	156	16
30 Jun 24	2,324	162	16
31 Mar 24	2,293	161	16
31 Dec 23	2,260	155	16
30 Sep 23	2,224	166	12
30 Jun 23	2,196	174	12
31 Mar 23	2,164	177	12
31 Dec 22	2,119	179	12
30 Sep 22	2,108	179	11
30 Jun 22	2,053	174	11
31 Mar 22	2,015	171	11
31 Dec 21	1,948	164	11
30 Sep 21	1,841	155	9
30 Jun 21	1,821	159	9
31 Mar 21	1,568	114	9
31 Dec 20	1,503	97	9
30 Sep 20	1,549	88	10
30 Jun 20	1,514	67	10
31 Mar 20	1,704	96	10
31 Dec 19	1,732	109	10
30 Sep 19	1,624	104	75
30 Jun 19	1,535	108	75
31 Mar 19	1,445	104	75
31 Dec 18	1,362	100	75
30 Sep 18	1,327	110	71
30 Jun 18	1,302	110	71
31 Mar 18	1,279	102	71
31 Dec 17	1,266	101	71
30 Sep 17	1,231	72	60
30 Jun 17	1,213	72	60
31 Mar 17	1,175	68	60
31 Dec 16	1,133	64	60
30 Sep 16	1,104	61	55
30 Jun 16	1,078	58	55
31 Mar 16	1,057	52	55
31 Dec 15	1,034	47	55
30 Sep 15	1,001	46	49
30 Jun 15	975	42	49
31 Mar 15	934	40	49
31 Dec 14	891	46	49
30 Sep 14	864	40	-144
30 Jun 14	835	31	-81
31 Mar 14	826	25	-17
31 Dec 13	827	13	48

Quality Earnings: AMP1 N has high quality earnings.

Growing Profit Margin: AMP1 N's current net profit margins (6.6%) are lower than last year (7.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: AMP1 N's earnings have grown by 12.1% per year over the past 5 years.

Accelerating Growth: AMP1 N's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: AMP1 N had negative earnings growth (-6.4%) over the past year, making it difficult to compare to the Healthcare industry average (15.6%).

Return on Equity

High ROE: AMP1 N's Return on Equity (13.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/17 13:23
End of Day Share Price	2024/09/19 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Amplifon S.p.A. is covered by 31 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Paola Saglietti	Banca Akros S.p.A. (ESN)
Hassan Al-Wakeel	Barclays
Hugo Solvet	BNP Paribas Exane